Health Catalyst Inc
NASDAQ:HCAT
Health Catalyst Inc
NASDAQ:HCAT
Price:
6.45 USD
-1.38%
Market Closed
Updated:
May 3, 2024
Section:
Relative Value
The Relative Value of one
HCAT
stock under the Base Case scenario is
15.09
USD.
Compared to the current market price of 6.45 USD,
Health Catalyst Inc
is
Undervalued by 57%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
HCAT
Relative Value
Base Case
15.09
USD
Undervaluation 57%
Valuation Multiples
Multiples Across Competitors
HCAT Competitors Multiples
Health Catalyst Inc Competitors
Health Catalyst Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Health Catalyst Inc
NASDAQ:HCAT
|
376m USD | 1.3 | -3.2 | -6.4 | -3.3 | |
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
32.7B USD | 13.8 | 62.3 | 62.1 | 66.9 | |
| US |
|
Cerner Corp
NASDAQ:CERN
|
27.9B USD | 4.8 | 47.3 | 19.6 | 38.6 | |
| US |
|
Change Healthcare Inc
NASDAQ:CHNG
|
9B USD | 2.6 | -116.8 | 16.5 | 111.6 | |
| AU |
|
Pro Medicus Ltd
ASX:PME
|
11.9B AUD | 81.1 | 170.1 | 117 | 117 | |
| US |
|
Inspire Medical Systems Inc
NYSE:INSP
|
7.5B USD | 12 | -354.5 | -188.1 | -174.8 | |
| JP |
|
M3 Inc
TSE:2413
|
1.1T JPY | 4.8 | 24.1 | 12.5 | 14.1 | |
| US |
|
Doximity Inc
NYSE:DOCS
|
4.6B USD | 9.7 | 33.1 | 22.2 | 23.6 | |
| SE |
|
Sectra AB
STO:SECT B
|
42.2B SEK | 25.7 | 99.3 | -65.3 | -65.3 | |
| US |
|
Evolent Health Inc
NYSE:EVH
|
3.1B USD | 1.6 | -21.9 | 25.9 | 275.5 | |
| US |
|
Certara Inc
NASDAQ:CERT
|
2.9B USD | 8 | -51.5 | 46.6 | 467.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
